Helge Waal

  • Professor emeritus
  • +47-23368992 / +47-23368900
 

Author network for Helge Waal by COREMINE medical


Publications 2018

Henriksen K, Jacobsen JA, Henriksen EM, Gomes L, Waal H, Krajci P (2018)
The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone®) in a Low Threshold Setting
Eur Addict Res, 24 (6), 286-292
DOI 10.1159/000495188, PubMed 30466108

Publications 2017

Edvardsen HE, Tverborgvik T, Frost J, Rogde S, Morild I, Waal H, Clausen T, Slørdal L, Vindenes V (2017)
Differences in combinations and concentrations of drugs of abuse in fatal intoxication and driving under the influence cases
Forensic Sci Int, 281, 127-133
DOI 10.1016/j.forsciint.2017.10.045, PubMed 29128652

Edvardsen HE, Tverborgvik T, Frost J, Rogde S, Morild I, Waal H, Clausen T, Slørdal L, Vindenes V (2017)
Corrigendum to "Differences in combinations and concentrations of drugs of abuse in fatal intoxication and driving under the influence cases" [Forensic Sci. Int. 281 (2017) 127-133]
Forensic Sci Int, 283, 219
DOI 10.1016/j.forsciint.2017.12.040, PubMed 29324351

Kjoesnes R, Waal H, Hauff E, Gossop M (2017)
Severe trauma among substance users in opioid maintenance treatment: users' assessment of worst trauma and clinical assessment of PTSD
Heroin Addict. Relat. Clin. Probl., 19 (1), 5-11

Nyhagen HT, Waal H (2017)
The ageing OMT patient
Nord. Stud. Alcohol Drugs, 34 (1), 72-79

Waal H, Morland J (2017)
Substance, punishment and social contagion- an unfortunate confusion
Tidsskr. Nor. Laegeforen., 137 (12-13), 857

Waal H, Mørland J (2017)
[Drugs, punishment and social contagion - an unfortunate mix]
Tidsskr Nor Laegeforen, 137 (4), 262
DOI 10.4045/tidsskr.17.0024, PubMed 28225228

Waal H, Mørland J (2017)
[No title available]
Tidsskr Nor Laegeforen, 137 (12-13), 857
DOI 10.4045/tidsskr.17.0505, PubMed 28655224

Publications 2016

Henriksen K, Waal H, Krajci P (2016)
Will non-compliant 'hard-to-treat' opioid-dependent patients profit from low threshold methadone treatment? A prospective 15-month evaluation of patients on Low Dosage Methadone treatment at Oslo University Hospital
Heroin Addict. Relat. Clin. Probl., 18 (3), 23-27

Publications 2015

Bernard JP, Khiabani HZ, Hilberg T, Karinen R, Slørdal L, Waal H, Mørland J (2015)
Characteristics of methadone-related fatalities in Norway
J Forensic Leg Med, 36, 114-20
DOI 10.1016/j.jflm.2015.09.011, PubMed 26439870

Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarkø L, Ravndal E (2015)
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009
Eur Addict Res, 21 (5), 253-61
DOI 10.1159/000381670, PubMed 25967268

Waal H (2015)
[Norway on the overdose top?]
Tidsskr Nor Laegeforen, 135 (18), 1624
DOI 10.4045/tidsskr.15.0690, PubMed 26442722

Publications 2014

Bukten A, Skurtveit S, Waal H, Clausen T (2014)
Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study
Addict Behav, 39 (10), 1504-9
DOI 10.1016/j.addbeh.2014.05.007, PubMed 24960556

Wüsthoff LE, Waal H, Gråwe RW (2014)
The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial
BMC Psychiatry, 14, 67
DOI 10.1186/1471-244X-14-67, PubMed 24597469

Waal H (2014)
[Advances in the detention cell]
Tidsskr Nor Laegeforen, 134 (3), 263
DOI 10.4045/tidsskr.14.0015, PubMed 24518445

Waal H, Clausen T, Gjersing L, Gossop M (2014)
Open drug scenes: responses of five European cities
BMC Public Health, 14, 853
DOI 10.1186/1471-2458-14-853, PubMed 25128331

Publications 2013

Bukten A, Røislien J, Skurtveit S, Waal H, Gossop M, Clausen T (2013)
A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study
BMC Psychiatry, 13, 262
DOI 10.1186/1471-244X-13-262, PubMed 24131480

Gjersing L, Jonassen KV, Biong S, Ravndal E, Waal H, Bramness JG, Clausen T (2013)
Diversity in causes and characteristics of drug-induced deaths in an urban setting
Scand J Public Health, 41 (2), 119-25
DOI 10.1177/1403494812472007, PubMed 23302498

Helseth V, Samet S, Johnsen J, Bramness JG, Waal H (2013)
Independent or Substance-Induced Mental Disorders? An Investigation of Comorbidity in an Acute Psychiatric Unit
J. Dual Diagn., 9 (1), 78-86

Sarfi M, Sundet JM, Waal H (2013)
Maternal stress and behavioral adaptation in methadone- or buprenorphine-exposed toddlers
Infant Behav Dev, 36 (4), 707-16
DOI 10.1016/j.infbeh.2013.08.006, PubMed 23999378

Waal H (2013)
Is sustained release natrexone an option for heroin-dependent pregnant women?
Addiction, 108 (2), 252-3
DOI 10.1111/j.1360-0443.2012.03940.x, PubMed 23331879

Waal H (2013)
[To embrace the weak]
Tidsskr Nor Laegeforen, 133 (11), 1166
DOI 10.4045/tidsskr.13.0216, PubMed 23759770

Waal H, Gossop M (2013)
Making sense of differing overdose mortality: contributions to improved understanding of European patterns
Eur Addict Res, 20 (1), 8-15
DOI 10.1159/000346781, PubMed 23921286

Publications 2012

Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J, Khiabani HZ (2012)
Methadone-related deaths in Norway
Forensic Sci Int, 224 (1-3), 111-6
DOI 10.1016/j.forsciint.2012.11.010, PubMed 23246070

Havnes I, Bukten A, Gossop M, Waal H, Stangeland P, Clausen T (2012)
Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study
Drug Alcohol Depend, 124 (3), 307-10
DOI 10.1016/j.drugalcdep.2012.02.005, PubMed 22382045

Pedersen K, Waal H, Kringlen E (2012)
Patients with nonaffective psychosis are at increased risk for heroin use disorders
Eur Addict Res, 18 (3), 124-9
DOI 10.1159/000334613, PubMed 22354141

Skeie I, Brekke M, Clausen T, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, Waal H (2012)
Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study
Eur Addict Res, 19 (4), 194-201
DOI 10.1159/000345229, PubMed 23257574

Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E (2012)
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Drug Alcohol Depend, 127 (1-3), 200-6
DOI 10.1016/j.drugalcdep.2012.07.001, PubMed 22841456

Wüsthoff LE, Waal H, Gråwe RW (2012)
When research meets reality-lessons learned from a pragmatic multisite group-randomized clinical trial on psychosocial interventions in the psychiatric and addiction field
Subst Abuse, 6, 95-106
DOI 10.4137/SART.S9245, PubMed 22933843

Waal H, Brekke M, Clausen T, Lindbæk M, Rosta J, Skeie I, Aasland OG (2012)
General practitioners' views on drug-assisted rehabilitation
Tidsskr Nor Laegeforen, 132 (16), 1861-6
DOI 10.4045/tidsskr.12.0124, PubMed 22986970

Publications 2011

Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T (2011)
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study
Addiction, 107 (2), 393-9
DOI 10.1111/j.1360-0443.2011.03637.x, PubMed 21883606

Bukten A, Skurtveit S, Stangeland P, Gossop M, Willersrud AB, Waal H, Havnes I, Clausen T (2011)
Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study
J Subst Abuse Treat, 41 (4), 407-14
DOI 10.1016/j.jsat.2011.06.006, PubMed 21839605

Lobmaier PP, Kunøe N, Gossop M, Waal H (2011)
Naltrexone depot formulations for opioid and alcohol dependence: a systematic review
CNS Neurosci Ther, 17 (6), 629-36
DOI 10.1111/j.1755-5949.2010.00194.x, PubMed 21554565

Sarfi M, Smith L, Waal H, Sundet JM (2011)
Risks and realities: dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment
Infant Behav Dev, 34 (4), 578-89
DOI 10.1016/j.infbeh.2011.06.006, PubMed 21824659

Skeie I, Brekke M, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, Waal H (2011)
Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study
BMJ Open, 1 (1), e000130
DOI 10.1136/bmjopen-2011-000130, PubMed 22021771

Vindenes V, Yttredal B, Oiestad EL, Waal H, Bernard JP, Mørland JG, Christophersen AS (2011)
Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine
J Anal Toxicol, 35 (1), 32-9
DOI 10.1093/anatox/35.1.32, PubMed 21219701

Wüsthoff LE, Waal H, Ruud T, Gråwe RW (2011)
A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres
BMC Psychiatry, 11, 93
DOI 10.1186/1471-244X-11-93, PubMed 21605358

Publications 2010

Anchersen K, Hansteen V, Gossop M, Clausen T, Waal H (2010)
Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor
Drug Alcohol Depend, 112 (3), 216-9
DOI 10.1016/j.drugalcdep.2010.06.015, PubMed 20702049

Bramness JG, Clausen T, Duckert F, Ravndal E, Waal H (2010)
Addiction research centres and the nurturing of creativity The Norwegian Centre for Addiction Research (SERAF)
Addiction, 106 (8), 1381-5
DOI 10.1111/j.1360-0443.2010.03086.x, PubMed 20735364

Gjersing L, Waal H, Caplehorn JR, Gossop M, Clausen T (2010)
Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment
BMC Health Serv Res, 10, 194
DOI 10.1186/1472-6963-10-194, PubMed 20604924

Kunoe N, Lobmaier P, Gossop M, Waal H (2010)
Naltrexone implants Reply
Br. J. Psychiatry, 196 (1), 77

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H (2010)
Challenges to antagonist blockade during sustained-release naltrexone treatment
Addiction, 105 (9), 1633-9
DOI 10.1111/j.1360-0443.2010.03031.x, PubMed 20707781

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen O, Waal H (2010)
Retention in naltrexone implant treatment for opioid dependence
Drug Alcohol Depend, 111 (1-2), 166-9
DOI 10.1016/j.drugalcdep.2010.03.021, PubMed 20570059

Lobmaier P, Gossop M, Waal H, Bramness J (2010)
The pharmacological treatment of opioid addiction--a clinical perspective
Eur J Clin Pharmacol, 66 (6), 537-45
DOI 10.1007/s00228-010-0793-6, PubMed 20169438

Lobmaier PP, Kunoe N, Waal H (2010)
Treatment research in prison: Problems and solutions in a randomized trial
Addict. Res. Theory, 18 (1), 1-13

Lobmaier PP, Kunøe N, Gossop M, Katevoll T, Waal H (2010)
Naltrexone implants compared to methadone: outcomes six months after prison release
Eur Addict Res, 16 (3), 139-45
DOI 10.1159/000313336, PubMed 20424458

Wüsthoff LE, Waal H, Ruud T, Røislien J, Gråwe RW (2010)
Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed
Nord J Psychiatry, 65 (1), 58-64
DOI 10.3109/08039488.2010.489954, PubMed 20507263

Waal H (2010)
NISUD—progress, backlash or sidetrack?
Addiction, 105 (12), 2050-1; discussion 2056
DOI 10.1111/j.1360-0443.2010.03116.x, PubMed 21105301

Waal H, Bramness JG (2010)
[Benzodiazepines to people with substance abuse problems?]
Tidsskr Nor Laegeforen, 130 (6), 610-2
DOI 10.4045/tidsskr.09.0687, PubMed 20349006

Publications 2009

Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H (2009)
Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study
Addiction, 104 (6), 993-9
DOI 10.1111/j.1360-0443.2009.02549.x, PubMed 19392907

Clausen T, Havnes IA, Waal H (2009)
[Overdose statistics--a complicated account]
Tidsskr Nor Laegeforen, 129 (21), 2233-6
DOI 10.4045/tidsskr.08.0605, PubMed 19898571

Clausen T, Waal H, Thoresen M, Gossop M (2009)
Mortality among opiate users: opioid maintenance therapy, age and causes of death
Addiction, 104 (8), 1356-62
DOI 10.1111/j.1360-0443.2009.02570.x, PubMed 19426288

Helseth V, Lykke-Enger T, Johnsen J, Waal H (2009)
Substance use disorders among psychotic patients admitted to inpatient psychiatric care
Nord J Psychiatry, 63 (1), 72-7
DOI 10.1080/08039480802450439, PubMed 19034727

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H (2009)
Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial
Br J Psychiatry, 194 (6), 541-6
DOI 10.1192/bjp.bp.108.055319, PubMed 19478295

Sarfi M, Martinsen H, Bakstad B, Røislien J, Waal H (2009)
Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine
Early Hum Dev, 85 (12), 773-8
DOI 10.1016/j.earlhumdev.2009.10.006, PubMed 19931991

Shaygani S, Waal H (2009)
[Treatment of opioid withdrawal]
Tidsskr Nor Laegeforen, 129 (2), 114-5
DOI 10.4045/tidsskr.09.32466, PubMed 19151804

Publications 2008

Skeie I, Brekke M, Lindbaek M, Waal H (2008)
Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study
BMC Public Health, 8, 43
DOI 10.1186/1471-2458-8-43, PubMed 18237421

Publications 2007

Clausen T, Anchersen K, Waal H (2007)
Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study
Drug Alcohol Depend, 94 (1-3), 151-7
DOI 10.1016/j.drugalcdep.2007.11.003, PubMed 18155364

Kornør H, Waal H, Sandvik L (2007)
Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status
Drug Alcohol Rev, 26 (2), 135-41
DOI 10.1080/09595230601146603, PubMed 17364848

Kunøe N, Waal H (2007)
Opioid overdose deaths can occur in patients with naltrexone implants
Med J Aust, 187 (1), 56; author reply 56-7
PubMed 17605713

Pedersen K, Sandvik L, Waal H (2007)
Evaluation of DTES - A simple drug-taking scale
Addict. Res. Theory, 15 (6), 637-649

Skeie I, Brekke M, Lindbaek M, Waal H (2007)
[General practitioners can take responsibility for medication-based rehabilitation]
Tidsskr Nor Laegeforen, 127 (3), 296-7
PubMed 17279108

Waal H (2007)
[Substance abuse and specialist health services]
Tidsskr Nor Laegeforen, 127 (3), 302
PubMed 17288038

Waal H (2007)
Merits and problems in high-threshold methadone maintenance treatment. Evaluation of medication-assisted rehabilitation in Norway 1998-2004
Eur Addict Res, 13 (2), 66-73
DOI 10.1159/000097935, PubMed 17356277

Waal H (2007)
[Dual diagnoses and dual messages]
Tidsskr Nor Laegeforen, 127 (15), 1922
PubMed 17700729

Waal H, Krook AL, Hansteen V (2007)
[Methadone and arrhythmia--final comment]
Tidsskr Nor Laegeforen, 127 (7), 913; author reply 913
PubMed 17435820

Waal H, Krook AL, Hansteen V (2007)
[Methadone treatment and heart arrhythmia]
Tidsskr Nor Laegeforen, 127 (4), 459; author reply 459-60
PubMed 17304281

Publications 2006

Kornør H, Waal H, Ali RL (2006)
Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling
Drug Alcohol Rev, 25 (2), 123-30
DOI 10.1080/09595230500537209, PubMed 16627301

Waal H, Frogopsahl G, Olsen L, Christophersen AS, Mørland J (2006)
Naltrexone implants -- duration, tolerability and clinical usefulness. A pilot study
Eur Addict Res, 12 (3), 138-44
DOI 10.1159/000092115, PubMed 16778434

Publications 2005

Kornør H, Waal H (2005)
From opioid maintenance to abstinence: a literature review
Drug Alcohol Rev, 24 (3), 267-74
DOI 10.1080/09595230500170241, PubMed 16096130

Publications 2004

Kornør H, Waal H (2004)
[Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation]
Tidsskr Nor Laegeforen, 124 (3), 332-4
PubMed 14963504

Krook AL, Waal H, Hansteen V (2004)
[Routine ECG in methadone-assisted rehabilitation is wrong prioritization]
Tidsskr Nor Laegeforen, 124 (22), 2940-1
PubMed 15550974

Olsen L, Christophersen AS, Frogopsahl G, Waal H, Mørland J (2004)
Plasma concentrations during naltrexone implant treatment of opiate-dependent patients
Br J Clin Pharmacol, 58 (2), 219-22
DOI 10.1111/j.1365-2125.2004.02122.x, PubMed 15255807

Waal H, Kornor H (2004)
Abstinence-oriented therapies for opiate addicts
Curr. Opin. Psychiatr., 17 (3), 169-174

Publications 2003

Bachs L, Waal H (2003)
[Naltrexone in the treatment of addiction]
Tidsskr Nor Laegeforen, 123 (12), 1665-7
PubMed 12821984

Waal H (2003)
[Tragedies in drunk cells]
Tidsskr Nor Laegeforen, 123 (8), 1047
PubMed 12760215

Waal H, Christophersen AS, Frogopsahl G, Olsen LH, Mørland J (2003)
[Naltrexone implants--a pilot project]
Tidsskr Nor Laegeforen, 123 (12), 1660-1
PubMed 12821982

Waal H, Aamodt Ø, Olsen H (2003)
[Use of naltrexone in the treatment of young drug addicts]
Tidsskr Nor Laegeforen, 123 (12), 1662-4
PubMed 12821983

Publications 2002

Bramness JG, Bachs LC, Waal H (2002)
[Buprenorphine as maintenance treatment in rehabilitation of heroin addicts]
Tidsskr Nor Laegeforen, 122 (25), 2452-4
PubMed 12448114

Krook AL, Brørs O, Dahlberg J, Grouff K, Magnus P, Røysamb E, Waal H (2002)
A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway
Addiction, 97 (5), 533-42
DOI 10.1046/j.1360-0443.2002.00090.x, PubMed 12033654

Waal H, Dahl IV (2002)
[From "quota prescription" to drug-assisted rehabilitation--experiences with the temporary guidelines]
Tidsskr Nor Laegeforen, 122 (12), 1228-31
PubMed 12089853

Publications 2001

Waal H, Krook AL, Welle-Strand G, Espegren O, Hole R, Lazaridis KB, Sandvold M, Moen S, Høiseth T (2001)
[A national model for drug-supported rehabilitation of opiate addicts]
Tidsskr Nor Laegeforen, 121 (19), 2301-5
PubMed 11571885

Publications 2000

Walby FA, Borg P, Eikeseth PH, Neegaard E, Kjerpeseth K, Bruvik S, Waal H (2000)
[Use of methadone in the treatment of psychotic patients with heroin dependence]
Tidsskr Nor Laegeforen, 120 (2), 195-8
PubMed 10851915

Publications 1999

Blix O, Bruvik S, Waal H (1999)
[The Oslo methadone project]
Tidsskr Nor Laegeforen, 119 (2), 242-6
PubMed 10081358

Waal H, Blix O, Krook A, Olsen H (1999)
[Methadone used in the treatment of opioid dependence]
Tidsskr Nor Laegeforen, 119 (2), 237-41
PubMed 10081357

Waal H, Morland J (1999)
Addiction as impeded rationality
ADDICTION: ENTRIES AND EXITS, 120-147

Publications 1998

Waal H (1998)
Understanding the incomprehensible - Limited rationality as an approach to "double-diagnosis" patients
Nord. J. Psychiatr., 52 (1), 23-29

Waal H (1998)
[Is methadone a solution?]
Tidsskr Nor Laegeforen, 118 (20), 3104
PubMed 9760849

Waal H (1998)
[Is methadone effective?]
Tidsskr Nor Laegeforen, 118 (23), 3673
PubMed 9820017

Waal H (1998)
[Dogmatism on methadone]
Tidsskr Nor Laegeforen, 118 (25), 3996
PubMed 9830350

Publications 1997

Waal H (1997)
Overstating the case - Methodological comments on 'the effects of harm reduction in Amsterdam' by Buning and van Brussel
Eur. Addict. Res., 3 (4), 199-204

Publications 1996

Waal H (1996)
[When your needs are most urgent, you will be denied help. Indistinct borderlines between advertisment, campaigns and information]
Tidsskr Nor Laegeforen, 116 (11), 1370-1
PubMed 8658420

Publications 1995

Faerden A, Waal H, Rønnow S (1995)
[Long-term psychiatric patients in a sector of Oslo]
Tidsskr Nor Laegeforen, 115 (29), 3638-41
PubMed 8539723

Rønnow S, Waal H (1995)
[Increasing number of involuntary emergency admissions to psychiatric institutions]
Tidsskr Nor Laegeforen, 115 (19), 2376-80
PubMed 7667852

Waal H (1995)
[Back to a more health-oriented narcotic policy?]
Tidsskr Nor Laegeforen, 115 (9), 1048-9
PubMed 7725281

Waal H (1995)
[To buy scientists?]
Tidsskr Nor Laegeforen, 115 (6), 734-5
PubMed 7900139

Publications 1993

Ersland S, Kringlen E, Waal H, Thaulow JF (1993)
[Lobotomy at the Gaustad hospital]
Tidsskr Nor Laegeforen, 113 (17), 2092-5
PubMed 8337667

Waal H, Kringlen E, Ersland S, Thaulow JF (1993)
[What can we learn from the lobotomy period?]
Tidsskr Nor Laegeforen, 113 (17), 2121-5
PubMed 8337674

Publications 1992

Waal H (1992)
[Methadone treatment of narcotic addicts--can it be defended?]
Tidsskr Nor Laegeforen, 112 (3), 374-5
PubMed 1553680

Publications 1991

Waal H, Knutsen T, Welle-Strand G (1991)
[Methadone maintenance of HIV-infected drug addicts with immune deficiency]
Tidsskr Nor Laegeforen, 111 (25), 3083-6
PubMed 1658974

Publications 1990

Knutsen T, Waal H (1990)
[Therapeutic and health care needs of HIV positive drug abusers. A study from an emergency institution]
Tidsskr Nor Laegeforen, 110 (22), 2861-3
PubMed 2219061

Publications 1989

Helgeland I, Waal H (1989)
[Can adolescents with behavioral disorders be helped? Problems among young people--behavioral disorders--preventive attempts--follow-up studies--evaluation]
Tidsskr Nor Laegeforen, 109 (14), 1509-12
PubMed 2749637

Waal H (1989)
[Buprenorphine (Temgesic)--a new agent for abuse]
Tidsskr Nor Laegeforen, 109 (12), 1326-7
PubMed 2734763

Waal H, Helgeland I (1989)
[Punishment, fostering, education and treatment. An integrated model for adolescents with behavioral disorders]
Tidsskr Nor Laegeforen, 109 (14), 1513-6
PubMed 2749638

Publications 1983

Dahl AA, Waal H (1983)
An outcome study of primal therapy
Psychother Psychosom, 39 (3), 154-64
DOI 10.1159/000287736, PubMed 6622628

Publications 1980

Holsten F, Waal H (1980)
The DTES - drug taking evaluation scale. A simple scale for the evaluation of drug taking behaviour
Acta Psychiatr Scand, 61 (4), 275-305
DOI 10.1111/j.1600-0447.1980.tb00582.x, PubMed 7446185

Holsten F, Waal H (1980)
Evaluation of the drug taker. A step to an evaluation of treatment
Acta Psychiatr Scand Suppl, 284, 29-41
PubMed 6935930

Waal H, Holsten F (1980)
Evaluation of drug taking behaviour. Some theoretical and methodological considerations
Acta Psychiatr Scand, 61 (2), 127-34
DOI 10.1111/j.1600-0447.1980.tb00572.x, PubMed 7361585

Publications 1977

Waal H (1977)
[Process- or task oriented evaluation?]
Tidsskr Nor Laegeforen, 97 (19-21), 1001-3
PubMed 898130

Waal H (1977)
[Occupational groups and milieu therapy - various comments]
Sykepleien, 64 (20), 1144-6
PubMed 245814

Waal H (1977)
[Organization and structural changes. Evaluation of open systems]
Tidsskr Nor Laegeforen, 97 (19-21), 1016-8
PubMed 898135

Waal H (1977)
[The new sex therapy]
Tidsskr Nor Laegeforen, 97 (4), 200-2
PubMed 841552

Waal H (1977)
[Evaluation of changes in the structure of a mental hospital]
Tidsskr Nor Laegeforen, 97 (19-21), 1035-9
PubMed 898142

Waal H (1977)
[Ward personnel in the psychiatric hospital keeper, caretaker, nurse or therapist?]
Sykepleien, 64 (18), 1019-21, 1037
PubMed 244025

Waal H (1977)
[Role changes for doctors, psychologists and trained social workers during structure changes at the psychiatric hospitals]
Tidsskr Nor Laegeforen, 97 (16), 846-8
PubMed 877937

Waal H, Baksaas R, Miljeteig M, Sundal N (1977)
[Team work situation in psychiatric hospital wards are changing]
Sykepleien, 64 (19), 1086-90
PubMed 244034

Publications 1973

Waal H (1973)
[Drug addiction and drug abuse in adolescence]
Tidsskr Nor Laegeforen, 93 (14), 1047-52
PubMed 4755947

Publications 1972

Waal H (1972)
[Chronic "sniffers"]
Tidsskr Nor Laegeforen, 92 (10), 701-6
PubMed 5028420

Publications 1971

Kofstad J, Boe G, Waal H (1971)
[Detection of drug abuse with thin-layer chromatography of urine]
Tidsskr Nor Laegeforen, 91 (9), 654-6
PubMed 5576180

Waal H (1971)
[The present status of adolescent drug addiction in Norway. Theoretical considerations, historical development and treatment offered]
Tidsskr Nor Laegeforen, 91 (5), 367-74
PubMed 5546519

Page visits: 2394